| Abstrakt: |
Mercer, a global consulting leader in advancing health, wealth and career, and a wholly owned subsidiary of Marsh & McLennan Companies (NYSE: MMC), announced the appointment of Andrew Halpert as Clinical Innovation Leader, Health, US & Canada. In this role, he will be responsible for leading the strategy and execution of Mercer’s clinical consulting offerings and health strategy development. Dr. Halpert will report to Jean Moore, Specialty and Innovation Leader, US & Canada. He is based in San Francisco. [ABSTRACT FROM PUBLISHER] |
